Pomerantz LLP is investigating claims on behalf of investors of Nektar Therapeutics ("Nektar" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or ...
Detailed price information for Soleno Therapeutics Inc (SLNO-Q) from The Globe and Mail including charting and trades.
Finnish beverage producer Olvi Group said it has completed the acquisition of Bosnia's largest brewery, Banjalucka Pivara, ...
January in Southeast Michigan is that special time of year when your body wants a nap and your spirit wants a party — and now ...
Nektar Therapeutics just saw its fair value model refreshed, with the headline number holding steady at US$114.43 per share ...
Analysts have nudged their fair value estimate for Nektar Therapeutics higher, from about $107.29 to $114.43 per share, even as their long term revenue growth outlook has become slightly more ...
Nektar Therapeutics (NASDAQ: NKTR) stock is trading lower Monday afternoon as the market continues to assess mixed topline results from the Phase 2b REZOLVE-AA trial of rezpegaldesleukin. Here’s what ...
Morgan Stanley also posted forecast-beating results for the fourth quarter as the US banking giant topped both revenue and ...
Wall Street trading got off to a mixed start on Friday as big-name tech firms looked set to carry their recent strong ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback